Cancer Therapy
Similar results shown in trial of darbepoetin alfa each 2 weeks versus Epoetin alfa weekly
Published in Medical Letter on the CDC and FDA, June 21st, 2006
The study demonstrated that Aranesp dosed every 2 weeks resulted in similar clinical efficacy as Epoetin alfa dosed once a week in boosting hemoglobin levels and reducing the need for red blood cell transfusions in cancer patients with chemotherapy-induced anemia.
"Results of this study, the largest, randomized head-to-head comparison of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Carcinogenesis
Bromate mutagenicity is due to oxidative damage causing chromosomal breakage - Child Abuse
Effects of abuse and related adverse experiences in childhood are long lasting - Genetics & Genomics
Gene expression correlates of unexplained fatigue are reported - HIV/AIDS Therapy
Strong HIV prevention programs provide lessons for effective interventions - Polio Vaccine
Reversions in 5'-untranslated region of poliovirus after vaccination are analyzed - Abdominal Aortic Aneurysms
Endologix receives U.S. Food and Drug Administration approval for Visiflex Delivery System - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
